US Stock MarketDetailed Quotes
GLMD Galmed Pharmaceuticals
- 0.3925
- -0.0075-1.88%
Close Apr 25 16:00 ET
- 0.3830
- -0.0095-2.42%
Post 17:23 ET
2.36MMarket Cap-157P/E (TTM)
0.3949High0.3600Low35.00KVolume0.3700Open0.4000Pre Close13.32KTurnover1.00%Turnover RatioLossP/E (Static)6.01MShares7.800052wk High0.17P/B1.38MFloat Cap0.260052wk Low--Dividend TTM3.51MShs Float405.9000Historical High--Div YieldTTM8.73%Amplitude0.2600Historical Low0.3800Avg Price1Lot Size
About Galmed Pharmaceuticals Company
Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
Company Profile
SymbolGLMD
Company NameGalmed Pharmaceuticals
Listing DateMar 13, 2014
Issue Price13.50
Founded2000
CEOMr. Allen Baharaff
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address16 Abba Hillel Road
CityRamat Gan
ProvinceTel Aviv
CountryIsrael
Zip Code5250608
Phone972-3-693-8448
Websitehttp://galmedpharma.com
Company Executives
- Name
- Position
- Salary
- Allen Baharaff
- Director, President and Chief Executive Officer
- 1.36M
- Guy Nehemya
- Chief Operating Officer and Data Protection Officer
- 350.21K
- Dr. Liat Hayardeny
- Chief Scientist Officer
- 239.89K
- Yohai Stenzler
- Chief Accounting Officer
- 354.14K
- Doron Cohen
- Chief Financial Officer
- 159.66K
- Shmuel Nir
- Independent Director
- --
- Amir Poshinski
- Independent Director
- --
- Dr. David Sidransky, M.D.
- Lead Independent Director
- --
- Dr. Carol L. Brosgart, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
